The impact of an individualized risk-adjusted approach on hypertension treatment in primary care

Journal of Clinical Hypertension

Volumn 19, Issue 5, 2017, Pages 510-518

  Zechmann, Stefan ^a   Senn, Oliver ^a   Valeri, Fabio ^a   Neuner Jehle, Stefan ^a   Rosemann, Thomas ^a   Djalali, Sima ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

antihypertensive therapy; clinical management of high blood pressure; primary care issues; risk assessment; treatment and diagnosis guidelines

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; COMORBIDITY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PATIENT CARE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PULSE PRESSURE; RISK ASSESSMENT; SEX DIFFERENCE; SWISS; BLOOD PRESSURE; CARDIOLOGY; COMPLICATION; DRUG EFFECTS; ORGANIZATION AND MANAGEMENT; PHYSIOLOGY; PRIMARY HEALTH CARE; PROCEDURES; RISK FACTOR; STANDARDS; SWITZERLAND; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CARDIOLOGY; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RISK FACTORS; SWITZERLAND;

EID: 85008457015     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12958     Document Type: Article

References (49)

1. WHO. World Health Organisation. World Health Statistics 2015. http://www.who.int/gho/publications/world_health_statistics/2015/en/. ISBN 978 92 4 069443 9 (PDF).
2. Patel SA, Winkel M, Ali MK, Narayan KM, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–253.
3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223.
4. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219.
5. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.
6. NICE. National Institute for health and Care Excellence. Hypertension in adults: diagnosis and management (CG127). Clinical guideline Published: 24 August 2011 nice.org.uk/guidance/cg127.
7. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–520.
8. Borghi C, Dormi A, D'Addato S, Gaddi A, Ambrosioni E, Brisighella Heart Study Working Party. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart Study. J Hypertens. 2004;22:1707–1716.
9. Chow CK, Teo KK, Rangarajan S, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 2013;310:959–968.
10. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA. 2010;303:2043–2050.
11. Wilkins K, Campbell NR, Joffres MR, et al. Blood pressure in Canadian adults. Health Rep. 2010;21:37–46.
12. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW. Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens. 2007;21:99–106.
13. Sarganas G, Neuhauser HK. Untreated, uncontrolled, and apparent resistant hypertension: results of the German Health Examination Survey 2008-2011. J Clin Hypertens (Greenwich). 2016;18:1146–1154.
14. Joffres M, Falaschetti E, Gillespie C, et al. Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study. BMJ Open. 2013;3:e003423.
15. Dechend R, Kaiser E, Derer W, et al. Guideline adherence in cardiovascular risk assessment and analysis in 15,000 hypertensive German patients in real life: results of the Prospective 3A Registry. J Clin Hypertens (Greenwich). 2012;14:496–501.
16. Djalali S. Evidence-performance gap in primary care revisited in patients with diabetes. Exp Clin Cardiol. 2014;20:1655–1664.
17. Markun S, Dishy A, Neuner-Jehle S, Rosemann T, Frei A. The chronic care for wet age related macular degeneration (CHARMED) study: a randomized controlled trial. PLoS ONE. 2015;10:e0143085.
18. Boeckxstaens P, Peersman W, Goubin G, et al. A practice-based analysis of combinations of diseases in patients aged 65 or older in primary care. BMC Fam Pract. 2014;15:159.
19. Afshar S, Roderick PJ, Kowal P, Dimitrov BD, Hill AG. Multimorbidity and the inequalities of global ageing: a cross-sectional study of 28 countries using the World Health Surveys. BMC Public Health. 2015;15:776.
20. Patel S, Kai J, Atha C, et al. Clinical characteristics of persistent frequent attenders in primary care: case-control study. Fam Pract. 2015;32:624–630.
21. Zellweger U, Bopp M, Holzer BM, Djalali S, Kaplan V. Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources. BMC Public Health. 2014;14:1157.
22. Djalali S, Senn O. Trends in family medicine – how to sort the wheat from the chaff. Praxis. 2015;104:1251–1258.
23. Heneghan C, Perera R, Mant D, Glasziou P. Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence. Br J Gen Pract. 2007;57:948–952.
24. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens. 2013;31:1281–1357.
25. Verbeke M, Schrans D, Deroose S, et al. The International Classification of Primary Care (ICPC-2): an essential tool in the EPR of the GP. Stud Health Technol Inform. 2006;124:809–814.
26. WONCA. World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians: ICPC-2-R: International Classification of Primary Care. Oxford: Oxford University Press; 2005.
27. WHO. World Health Organisation. Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2013. Oslo, 2012. https://www.whocc.no/filearchive/publications/1_2013guidelines.pdf. ISBN 978-82-8082-525-4.
28. Chmiel C, Bhend H, Senn O, Zoller M, Rosemann T, FIRE Study-Group. The FIRE project: a milestone for research in primary care in Switzerland. Swiss Med Wkly. 2011;140:w13142.
29. Lamers LM, van Vliet RC. The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation. Health Policy. 2004;68:113–121.
30. O'Halloran J, Miller GC, Britt H. Defining chronic conditions for primary care with ICPC-2. Fam Pract. 2004;21:381–386.
31. O'Rourke MF, Adji A. Guidelines on guidelines: focus on isolated systolic hypertension in youth. J Hypertens. 2013;31:649–654.
32. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014;23:3–16.
33. WHO. Programmes: Health Statistics and Information Systems: Definition of an Older or Elderly Person. World Health Organization. http://www.who.int/healthinfo/survey/ageingdefnolder/en/#. Accessed November 26, 2015.
34. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens. 2011;5:259–352.
35. Hansson L, Lithell H, Skoog I, et al. Study on COgnition and Prognosis in the Elderly (SCOPE). Blood Press. 1999;8:177–183.
36. Tobi H, van den Berg PB, de Jong-van den Berg LT. Small proportions: what to report for confidence intervals? Pharmacoepidemiol Drug Saf. 2005;14:239–247.
37. Bromfield SG, Bowling CB, Tanner RM, et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010. J Clin Hypertens (Greenwich). 2014;16:270–276.
38. Tocci G, Muiesan ML, Parati G, et al. Trends in prevalence, awareness, treatment, and control of blood pressure recorded from 2004 to 2014 during world hypertension day in Italy. J Clin Hypertens (Greenwich). 2016;18:551–556.
39. Navar-Boggan AM, Pencina MJ, Williams K, Sniderman AD, Peterson ED. Proportion of US adults potentially affected by the 2014 hypertension guideline. JAMA. 2014;311:1424–1429.
40. Probstfield JL, Applegate WB, Borhani NO, et al. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Clin Exp Hypertens A. 1989;11:973–989.
41. Luijks H, Biermans M, Bor H, et al. The effect of comorbidity on glycemic control and systolic blood pressure in type 2 diabetes: a Cohort study with 5 year follow-up in primary care. PLoS ONE. 2015;10:e0138662.
42. Wright JT Jr, Williamson JD, Whelton PK, et al. A randomized trial of intensive versus standard blood-pressure control. N Eng J Med. 2015;373:2103–2116.
43. Ettehad D, Emdin CA, Kiran A, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2015;387:957–967.
44. Brenk-Franz K, Strauss B, Tiesler F, et al. The influence of adult attachment on patient self-management in primary care––the need for a personalized approach and patient-centred care. PLoS ONE. 2015;10:e0136723.
45. Guessous I, Bochud M, Theler JM, Gaspoz JM, Pechere-Bertschi A. 1999-2009 Trends in prevalence, unawareness, treatment and control of hypertension in Geneva, Switzerland. PLoS ONE. 2012;7:e39877.
46. Neuhauser HK, Adler C, Rosario AS, Diederichs C, Ellert U. Hypertension prevalence, awareness, treatment and control in Germany 1998 and 2008-11. J Hum Hypertens. 2014;29:247–253.
47. Bramlage P, Thoenes M, Kirch W, Lenfant C. Clinical practice and recent recommendations in hypertension management – reporting a gap in a global survey of 1259 primary care physicians in 17 countries. Curr Med Res Opin. 2007;23:783–791.
48. Grobbee D, Hoes A, Verheij TM, Schrijvers AP, Ameijden ECV, Numans M. The Utrecht Health Project: optimization of routine healthcare data for research. Eur J Epidemiol. 2005;20:285–290.
49. Smeets HM, de Wit NJ, Hoes AW. Routine health insurance data for scientific research: potential and limitations of the Agis Health Database. J Clin Epidemiol. 2011;64:424–430.